Mehmet Turgut

Mehmet Turgut

Ondokuz Mayıs University - Samsun / Türkiye
Medical and Health Sciences / Hematology
AD Scientific Index ID: 80837
On Dokuz Mayıs Üniversitesi
person_outline Mehmet Turgut's MOST POPULAR ARTICLES
1-) Azacitidine and venetoclax in previously untreated acute myeloid leukemiaCD DiNardo, BA Jonas, V Pullarkat, MJ Thirman, JS Garcia, AH Wei, ...New England Journal of Medicine 383 (7), 617-629, 20209352020
2-) Daratumumab plus bortezomib, melphalan, and prednisone for untreated myelomaMV Mateos, MA Dimopoulos, M Cavo, K Suzuki, A Jakubowiak, S Knop, ...New England Journal of Medicine 378 (6), 518-528, 20188182018
3-) Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin’s lymphomaJM Connors, W Jurczak, DJ Straus, SM Ansell, WS Kim, A Gallamini, ...New England Journal of Medicine 378 (4), 331-344, 20185872018
4-) Randomized phase III trial of ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in non–germinal center B-cell diffuse large B-cell lymphomaA Younes, LH Sehn, P Johnson, PL Zinzani, X Hong, J Zhu, C Patti, ...Journal of Clinical Oncology 37 (15), 1285-1295, 20195962019
5-) Daratumumab-based treatment for immunoglobulin light-chain amyloidosisE Kastritis, G Palladini, MC Minnema, AD Wechalekar, A Jaccard, HC Lee, ...New England Journal of Medicine 385 (1), 46-58, 20214942021